Dengue researcher faces charges in vaccine fiasco

Rose Capeding could face years in prison for role in tests. Rose Capeding, former head of the dengue department of the Research Institute for Tropical Medicine in Manila, has been indicted in a series of criminal cases over the failed introduction in the Philippines of Dengvaxia, a vaccine against d...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 364; no. 6438; p. 320
Main Author Arkin, Fatima
Format Journal Article
LanguageEnglish
Published United States 26.04.2019
Online AccessGet full text

Cover

More Information
Summary:Rose Capeding could face years in prison for role in tests. Rose Capeding, former head of the dengue department of the Research Institute for Tropical Medicine in Manila, has been indicted in a series of criminal cases over the failed introduction in the Philippines of Dengvaxia, a vaccine against dengue that was yanked from the market in 2017 because of safety issues. In February, a panel of prosecutors concluded that there is probable cause to indict Capeding and 19 others for "reckless imprudence resulting [in] homicide," because of their role in the vaccine's approval and rollout. If convicted of accusations leveled at her by the national Department of Justice, Capeding could face up to 48 years in prison. Many scientists have come to her defense.
Bibliography:SourceType-Other Sources-1
ObjectType-News-1
content type line 66
ISSN:0036-8075
1095-9203
DOI:10.1126/science.364.6438.320